Research Insight

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Medtronic has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its MiniMed Go™ app, enabling the launch of the MiniMed Go Smart MDI...

Real-world evidence represents clinical data collected outside traditional controlled trial environments, derived from sources including electronic health records, insurance claims databases, disease registries, wearable devices, and patient-reported outcomes.

FUJIFILM Corporation today announced that it has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognized for its...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that a presentation related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH,...

Measuring Success: KPIs and Metrics for Digital Health Initiatives The measurement and evaluation of digital health initiatives has evolved into a sophisticated discipline that requires comprehensive...